Intrepid Financial Planning Group LLC Sarepta Therapeutics, Inc. Transaction History
Intrepid Financial Planning Group LLC
- $234 Million
- Q4 2024
A detailed history of Intrepid Financial Planning Group LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 2,075 shares of SRPT stock, worth $151,226. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,075
Previous 2,075
-0.0%
Holding current value
$151,226
Previous $259,000
2.7%
% of portfolio
0.11%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
534Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$752 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$662 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$634 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$315 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$297 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.38B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...